- ￥400 - 4480
- MedChemExpress(MCE)
- 美国
- HY-138696
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
4°C, protect from light
- 英文名：
XL092
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥1046.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥400.0 |
| 规格： | 5 mg | 产品价格： | ￥550.0 |
| 规格： | 10 mg | 产品价格： | ￥875.0 |
| 规格： | 25 mg | 产品价格： | ￥1750.0 |
| 规格： | 50 mg | 产品价格： | ￥2800.0 |
| 规格： | 100 mg | 产品价格： | ￥4480.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Zanzalintinib
CAS No. : 2367004-54-2
MCE 国际站：Zanzalintinib
产品活性：Zanzalintinib (XL092) 是一种口服有效的，ATP 竞争性的多受体酪氨酸激酶 (RTKs) 抑制剂，包括 MET、VEGFR2、AXL 和 MER，在细胞分析中的 IC50 值分别为 15 nM、1.6 nM、3.4 nM 和 7.2 nM。Zanzalintinib 具有抗肿瘤活性。Zanzalintinib 具有用于研究激酶依赖性疾病的潜力。
研究领域：Protein Tyrosine Kinase/RTK
作用靶点：TAM Receptor | c-Met/HGFR | VEGFR
In Vivo: Zanzalintinib (10 mg/kg/day; oral; for 14 days) causes substantial tumor growth inhibition in xenograft studies. Zanzalintinib shows 82% and 96% inhibition on p-MET and p-VEGFR2, respectively.
Zanzalintinib (compound 8; 3 mg/kg; iv) has a T1/2 of 5.4 hours, a CL of 43 mL/hr kg. Zanzalintinib (3 mg/kg; po) has a T1/2 of 7.1 hours and a Cmax of 11.4 μM for rats.
相关产品：Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Differentiation Inducing Compound Library | Reprogramming Compound Library | Orally Active Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Angiogenesis-Related Compound Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Cytokine Inhibitors Library | Sorafenib | Lenvatinib | Sunitinib | Regorafenib | Afatinib | Nintedanib | Bevacizumab | Semaxinib | Cabozantinib | Crizotinib | Bemcentinib | Gilteritinib | Ponatinib | Axitinib | Capmatinib | Midostaurin | Chloramphenicol | Pazopanib | PD173074 | 5Z-7-Oxozeaenol | Linifanib | Tanshinone IIA | Vandetanib | Foretinib | SU 5402 | Savolitinib | 2-D08 | Fruquintinib
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
